Effect of covalent dimer conjugates of angiotensin II on receptor affinity and activity in vitro.
暂无分享,去创建一个
[1] P. Timmermans,et al. Identification of angiotensin II receptor subtypes. , 1989, Biochemical and biophysical research communications.
[2] S. Whitebread,et al. Preliminary biochemical characterization of two angiotensin II receptor subtypes. , 1989, Biochemical and biophysical research communications.
[3] P. Portoghese. Bivalent ligands and the message-address concept in the design of selective opioid receptor antagonists. , 1989, Trends in pharmacological sciences.
[4] J. Fauchère,et al. Synthesis and steroidogenic activity of covalently dimerized corticotropin (ACTH) fragments , 1988 .
[5] J. Fauchère,et al. Potentiation of the antagonistic effect of ACTH11–24 on steroidogenesis by synthesis of covalent dimeric conjugates , 1985, FEBS letters.
[6] D. L. Larson,et al. Opioid agonist and antagonist bivalent ligands as receptor probes. , 1982, Life sciences.
[7] J. Russell,et al. Preparation of a disulfide-linked dimer of human placental lactogen fragment 1--134 with immunologic and biologic activity. , 1979, Proceedings of the National Academy of Sciences of the United States of America.
[8] C. Sandman,et al. Increased analgesic activities of a fluorinated and a dimeric analogue of [D-Ala-2]-methionine enkephalinamide. , 1978, Biochemical and biophysical research communications.
[9] S. Whitebread,et al. Binding characteristics and vascular effects of various angiotensin II antagonists. , 1990, Journal of cardiovascular pharmacology.
[10] M. Stolz. Kovalente Dimerisierung von Neuropeptid-Agonisten und Antagonisten , 1988 .